Skip to content
← Index board

Health Optimization Index

TRT (Testosterone Replacement Therapy)

Nick’s assessment
Experimental
Research evidence
A, strong evidence
Attention
11.2 / 100▼ Falling this week
5.7/ 10

BioHarmony score

TRT can be high-upside for men with documented symptomatic hypogonadism: the T Trials support sexual-function and mood benefits, while TRAVERSE lowered concern about major cardiovascular events but left AF, pulmonary embolism, blood-pressure, fertility, and dependency concerns.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

TRT (Testosterone Replacement Therapy) is a 5.5–6.0/10 fit for people weighing hormonal, libido, and energy, especially when the goal is a tracked experiment with clear endpoints. The strongest evidence anchor is Xu 2024: 28 RCTs, 3,461 patients; erectile-function scores improved without statistically significant intermediate-term prostate or urinary worsening. Zarrouf 2009 adds a second signal, but TRT (Testosterone Replacement Therapy) still has gaps around large trials, long-term outcomes, responder profiles, or real-world adherence. That makes TRT (Testosterone Replacement Therapy) useful for a defined reader, while weaker for broad anti-aging or catch-all wellness claims. In practice, TRT (Testosterone Replacement Therapy) belongs after basics, diagnosis when relevant, and a stop rule based on symptoms, labs, sleep, or performance.

✅ Best for: Men 35+ with documented symptomatic hypogonadism on two separate morning tests who already addressed sleep, body composition, alcohol, micronutrients, training, medications, and stress. Men with primary hypogonadism where lifestyle will not restore levels. Older hypogonadal men with sarcopenia, anemia, low bone density, low libido, or persistent depressive symptoms under careful monitoring. Men with hypogonadism plus type 2 diabetes or metabolic syndrome when TRT is prescribed for deficiency symptoms, not as glucose medicine. Competitive athletes only if medically indicated and covered by a valid WADA therapeutic-use exemption.

❌ Avoid if: You have one low or borderline testosterone result without repeat morning confirmation, fertility plans in the next 12 months without a urology plan, untreated severe sleep apnea, baseline polycythemia, thrombophilia, uncontrolled hypertension, severe heart failure, recent MI or stroke, active prostate or breast cancer, unexplained PSA rise, or a clinic that skips LH, FSH, hematocrit, estradiol-sensitive, PSA when age-appropriate, and lifestyle review. Also avoid TRT as a first move for fatigue, brain fog, low motivation, or body recomposition when sleep, training, calories, alcohol, and medications are unresolved.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on TRT (Testosterone Replacement Therapy)
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 14, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.